Mert Sarilar, V. Oktay, Gursu Demirci, D. Oksen, V. Sansoy
{"title":"稳定型心绞痛择期经皮冠状动脉介入治疗后围手术期心肌损伤:三级中心经验","authors":"Mert Sarilar, V. Oktay, Gursu Demirci, D. Oksen, V. Sansoy","doi":"10.33678/cor.2022.111","DOIUrl":null,"url":null,"abstract":"Background: Periprocedural myocardial injury and its clinical signifi cance in stable patients are still under discussion. This subject has been assessed in many studies with different defi nitions, thresholds, and biomarkers for years. This study aimed to determine the clinical outcomes of periprocedural myocardial injury based on latest 4th UDMI guideline defi nitions. Methods: 238 patients who underwent elective percutaneous coronary intervention at single center were retrospectively enrolled. Patients who developed periprocedural myocardial injury were compared with patients with normal troponin values after the procedure for clinical outcomes. Primary clinical endpoints were death, MI, stroke, refractory angina, target vessel revascularization and hospitalization due to acute coronary syndrome at one year. Results: Periprocedural myocardial injury was observed in 67.2% (n = 160) of patients. Number of lesions and stents, total stent length, total stent diameter, post-dilatation, overlapping stents, bifurcation stenting and SYNTAX score were signifi cantly higher in myocardial injury group. Clinical outcomes occurred in 16 patients, 11 of 16 had myocardial injury group, 5 of 16 had control group. No mortality was seen during the follow-up. Postprocedural troponin elevation was not associated with clinical outcomes (11 vs. 5, p = 0,56). Kaplan–Meier curve of clinical end points did not show any separation between the curves (Log rank test, 95% CI, p = 0,71). Conclusion: Stent size and length, post-dilatation, overlapping stents and stenting of bifurcation lesions lead to increase in myocardial injury. Periprocedural myocardial injury in stable angina does not predict clinical outcomes at one year.","PeriodicalId":10787,"journal":{"name":"Cor et vasa","volume":" ","pages":""},"PeriodicalIF":0.2000,"publicationDate":"2023-06-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Periprocedural myocardial injury after elective percutaneous coronary intervention in stable angina pectoris: a tertiary center experience\",\"authors\":\"Mert Sarilar, V. Oktay, Gursu Demirci, D. Oksen, V. Sansoy\",\"doi\":\"10.33678/cor.2022.111\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Background: Periprocedural myocardial injury and its clinical signifi cance in stable patients are still under discussion. This subject has been assessed in many studies with different defi nitions, thresholds, and biomarkers for years. This study aimed to determine the clinical outcomes of periprocedural myocardial injury based on latest 4th UDMI guideline defi nitions. Methods: 238 patients who underwent elective percutaneous coronary intervention at single center were retrospectively enrolled. Patients who developed periprocedural myocardial injury were compared with patients with normal troponin values after the procedure for clinical outcomes. Primary clinical endpoints were death, MI, stroke, refractory angina, target vessel revascularization and hospitalization due to acute coronary syndrome at one year. Results: Periprocedural myocardial injury was observed in 67.2% (n = 160) of patients. Number of lesions and stents, total stent length, total stent diameter, post-dilatation, overlapping stents, bifurcation stenting and SYNTAX score were signifi cantly higher in myocardial injury group. Clinical outcomes occurred in 16 patients, 11 of 16 had myocardial injury group, 5 of 16 had control group. No mortality was seen during the follow-up. Postprocedural troponin elevation was not associated with clinical outcomes (11 vs. 5, p = 0,56). Kaplan–Meier curve of clinical end points did not show any separation between the curves (Log rank test, 95% CI, p = 0,71). Conclusion: Stent size and length, post-dilatation, overlapping stents and stenting of bifurcation lesions lead to increase in myocardial injury. Periprocedural myocardial injury in stable angina does not predict clinical outcomes at one year.\",\"PeriodicalId\":10787,\"journal\":{\"name\":\"Cor et vasa\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":0.2000,\"publicationDate\":\"2023-06-20\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Cor et vasa\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.33678/cor.2022.111\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"CARDIAC & CARDIOVASCULAR SYSTEMS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cor et vasa","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.33678/cor.2022.111","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0
摘要
背景:稳定患者术中心肌损伤及其临床意义仍在讨论中。多年来,这一主题在许多具有不同定义、阈值和生物标志物的研究中得到了评估。本研究旨在根据最新的第4版UDMI指南定义确定围手术期心肌损伤的临床结果。方法:238例在单中心行择期经皮冠状动脉介入治疗的患者进行回顾性分析。术后发生围手术期心肌损伤的患者与肌钙蛋白值正常的患者进行临床结果比较。主要临床终点为一年内死亡、心肌梗死、卒中、难治性心绞痛、靶血管重建术和因急性冠状动脉综合征住院。结果:术中心肌损伤发生率为67.2%(160例)。心肌损伤组病变及支架数量、支架总长度、支架总直径、扩张后、支架重叠、支架术分岔及SYNTAX评分均显著高于心肌损伤组。16例患者发生临床结局,16例中心肌损伤组11例,对照组5例。随访期间未见死亡。术后肌钙蛋白升高与临床结果无关(11比5,p = 0,56)。Kaplan-Meier曲线的临床终点之间没有任何分离(Log rank检验,95% CI, p = 0,71)。结论:支架的大小和长度、扩张后支架、重叠支架和分叉病变支架置入导致心肌损伤增加。稳定性心绞痛围手术期心肌损伤不能预测一年后的临床结果。
Periprocedural myocardial injury after elective percutaneous coronary intervention in stable angina pectoris: a tertiary center experience
Background: Periprocedural myocardial injury and its clinical signifi cance in stable patients are still under discussion. This subject has been assessed in many studies with different defi nitions, thresholds, and biomarkers for years. This study aimed to determine the clinical outcomes of periprocedural myocardial injury based on latest 4th UDMI guideline defi nitions. Methods: 238 patients who underwent elective percutaneous coronary intervention at single center were retrospectively enrolled. Patients who developed periprocedural myocardial injury were compared with patients with normal troponin values after the procedure for clinical outcomes. Primary clinical endpoints were death, MI, stroke, refractory angina, target vessel revascularization and hospitalization due to acute coronary syndrome at one year. Results: Periprocedural myocardial injury was observed in 67.2% (n = 160) of patients. Number of lesions and stents, total stent length, total stent diameter, post-dilatation, overlapping stents, bifurcation stenting and SYNTAX score were signifi cantly higher in myocardial injury group. Clinical outcomes occurred in 16 patients, 11 of 16 had myocardial injury group, 5 of 16 had control group. No mortality was seen during the follow-up. Postprocedural troponin elevation was not associated with clinical outcomes (11 vs. 5, p = 0,56). Kaplan–Meier curve of clinical end points did not show any separation between the curves (Log rank test, 95% CI, p = 0,71). Conclusion: Stent size and length, post-dilatation, overlapping stents and stenting of bifurcation lesions lead to increase in myocardial injury. Periprocedural myocardial injury in stable angina does not predict clinical outcomes at one year.